title: The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment.
abstract: Highly active antiretroviral therapy has been effective in lowering viral loads in the peripheral blood, restoring immune function and reducing the incidence of opportunistic infections and dementia in human immunodeficiency virus (HIV)-infected individuals. However, motor and cognitive deficits and peripheral neuropathy continue, with some studies reporting an increase in prevalence of nervous system disease. The authors developed an accelerated, consistent simian model of HIV infection in which pigtailed macaques are dual inoculated with a neurovirulent simian immunodeficiency virus (SIV) clone and an immunosuppressive SIV strain. Infected animals invariably develop acquired immunodeficiency syndrome (AIDS) and over 90% develop central nervous system disease as well as peripheral nervous system disease with neurodegeneration by 3 months postinoculation. This model provides outstanding opportunities to delineate the pathogenesis of infection, to study the regulation of virus gene expression, and to identify host immune responses throughout the acute, clinically silent and late stages of infection. Using this model, the authors have demonstrated that the virus enters the brain within days after inoculation, that CCL2 (monocyte chemoattractant protein [MCP]-1) plays a major role in recruiting monocytes/macrophages to the brain, and that type I interferons are critical in suppressing early virus replication and inducing viral latency. This model provides a rigorous platform for the testing of potential antiretroviral, immune reconstituting, and/or neuroprotective agents and already has been used to confirm the neuroprotective properties of minocycline, which now is being tested in clinical trials of HIV-infected individuals.
authors.affiliation: Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
authors.forename: Janice E
authors.initials: JE
authors.lastname: Clements
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Mankowski
authors.forename: Lucio
authors.initials: L
authors.lastname: Gama
authors.forename: M Christine
authors.initials: MC
authors.lastname: Zink
mesh_terms: D000818:Animals; D001921:Brain / Q000821:virology; D004195:Disease Models, Animal; D005838:Genotype; D008251:Macaca / Q000821:virology*; D009422:Nervous System Diseases / Q000209:etiology* / Q000628:therapy / Q000821:virology; D016097:Simian Acquired Immunodeficiency Syndrome / Q000503:physiopathology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000502:physiology*
references.citation: J Virol. 1995 Dec;69(12):7982-90
references.pmid: 7494311
references.citation: J Infect Dis. 2006 Apr 1;193(7):963-70
references.pmid: 16518758
references.citation: Nat Med. 2000 Jul;6(7):797-801
references.pmid: 10888929
references.citation: J Virol. 2003 Jun;77(12):6855-66
references.pmid: 12768005
references.citation: J Infect Dis. 2001 Oct 15;184(8):1015-21
references.pmid: 11574916
references.citation: J Neurovirol. 2002 Dec;8 Suppl 2:42-8
references.pmid: 12491150
references.citation: Neurology. 2006 Jun 13;66(11):1679-87
references.pmid: 16769940
references.citation: J Neuropathol Exp Neurol. 2005 Mar;64(3):202-8
references.pmid: 15804051
references.citation: Ann Neurol. 2002 Jul;52(1):54-61
references.pmid: 12112047
references.citation: J Neuropathol Exp Neurol. 2007 Jan;66(1):26-34
references.pmid: 17204934
references.citation: Neurology. 1994 Mar;44(3 Pt 1):474-81
references.pmid: 8145918
references.citation: HIV Med. 2007 Sep;8(6):367-73
references.pmid: 17661844
references.citation: J Neurovirol. 1996 Dec;2(6):423-32
references.pmid: 8972425
references.citation: Acta Neuropathol. 1996 Nov;92(5):487-98
references.pmid: 8922061
references.citation: AIDS. 2006 Jan 9;20(2):197-205
references.pmid: 16511412
references.citation: Neurology. 1994 Mar;44(3 Pt 1):481-7
references.pmid: 8145919
references.citation: Ann Neurol. 2004 May;55(5):756
references.pmid: 15122721
references.citation: J Neurosci. 2006 Oct 4;26(40):10299-304
references.pmid: 17021185
references.citation: J Med Primatol. 2002 Aug;31(4-5):171-8
references.pmid: 12390539
references.citation: J Neuroimmunol. 2004 Dec;157(1-2):66-70
references.pmid: 15579282
references.citation: J Exp Med. 1998 Dec 7;188(11):2057-65
references.pmid: 9841919
references.citation: Arthritis Rheum. 2001 Oct;44(10):2235-41
references.pmid: 11665963
references.citation: CNS Drugs. 2002;16(9):595-609
references.pmid: 12153332
references.citation: J Virol. 1999 Dec;73(12):10480-8
references.pmid: 10559366
references.citation: Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14669-74
references.pmid: 11724929
references.citation: J Neurovirol. 2002 Apr;8(2):136-42
references.pmid: 11935465
references.citation: J Neurovirol. 2004;10 Suppl 1:15-20
references.pmid: 14982734
references.citation: Brain Pathol. 1996 Jan;6(1):1-15
references.pmid: 8866743
references.citation: J Infect Dis. 2002 Oct 1;186(7):905-13
references.pmid: 12232830
references.citation: Clin Neuropharmacol. 2003 Jan-Feb;26(1):18-23
references.pmid: 12567160
references.citation: Virology. 1993 Aug;195(2):616-26
references.pmid: 8337835
references.citation: Nature. 2002 May 2;417(6884):74-8
references.pmid: 11986668
references.citation: Ann Neurol. 2006 May;59(5):816-24
references.pmid: 16634006
references.citation: J Neuropathol Exp Neurol. 1999 Nov;58(11):1156-62
references.pmid: 10560658
references.citation: J Virol. 1997 Aug;71(8):5790-8
references.pmid: 9223467
references.citation: J Exp Med. 1998 Oct 5;188(7):1255-65
references.pmid: 9763605
references.citation: J Neurovirol. 2003 Aug;9(4):452-64
references.pmid: 12907390
references.citation: J Neurovirol. 2000 Jun;6(3):173-86
references.pmid: 10878708
references.citation: Am J Pathol. 1996 Oct;149(4):1097-104
references.pmid: 8863658
references.citation: Nat Rev Immunol. 2003 Jun;3(6):493-502
references.pmid: 12776209
references.citation: J Neurovirol. 2003 Apr;9(2):205-21
references.pmid: 12707851
references.citation: JAMA. 2005 Apr 27;293(16):2003-11
references.pmid: 15855434
references.citation: Clin Immunol Immunopathol. 1990 Feb;54(2):200-19
references.pmid: 1688522
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14742-7
references.pmid: 9405683
references.citation: J Virol. 1997 Aug;71(8):6055-60
references.pmid: 9223498
references.citation: J Immunol. 2007 Dec 1;179(11):7262-9
references.pmid: 18025168
references.citation: Ann Neurol. 2002 Feb;51(2):215-23
references.pmid: 11835378
references.citation: J Clin Exp Neuropsychol. 1990 Oct;12(5):766-80
references.pmid: 2258436
references.citation: J Neurol Neurosurg Psychiatry. 2000 Sep;69(3):376-80
references.pmid: 10945813
references.citation: Semin Immunol. 1998 Jun;10(3):215-23
references.pmid: 9653048
references.citation: Neurology. 1992 Sep;42(9):1736-9
references.pmid: 1513462
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4005-10
references.pmid: 9108095
references.citation: Am J Pathol. 1997 Sep;151(3):793-803
references.pmid: 9284828
references.citation: J Neuropathol Exp Neurol. 2002 Jan;61(1):85-90
references.pmid: 11829347
references.citation: Arch Neurol. 2008 Jan;65(1):65-70
references.pmid: 18195140